EGFR and brain neoplasm: H&E staining confirmed the presence of brain tumors and immunofluorescence staining with anti-EGFR, anti-DR4, and anti-DR5 antibodies confirmed the expression of the receptors specifically in the neoplastic space (Fig. 6D—upper panel).